Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

Newly Discovered Mutation Causes Eye Disease

By Brandon Levy

Tuesday, September 25, 2018

This image shows the damaged retina of a patient with a genetic mutation discovered by IRP investigators that causes the eye disease retinitis pigmentosa. 

The Human Genome Project gave scientists an incredible roadmap of the thousands of genes used to construct the human body. However, many individuals harbor DNA that differs markedly from the standard reference sequence produced by that initiative, and these variations can have profound implications for a person’s health. A recent study led by IRP scientists has uncovered yet another of these genetic variants, a rare mutation that causes the eye disease retinitis pigmentosa.1

Retinitis pigmentosa is one of the most common diseases of the retina, the part of the eye that contains light-sensing cells called photoreceptors. In patients with the condition, the photoreceptors degenerate over time, leading first to poor night vision and deteriorating peripheral vision and eventually causing substantial vision loss that leaves patients legally blind.

Mutations in more than 50 genes are known to cause retinitis pigmentosa. IRP senior investigator J. Fielding Hejtmancik, M.D., Ph.D., has been working for over a decade with researchers at Johns Hopkins University and the Center for Excellence in Molecular Biology in Lahore, Pakistan, to identify previously unknown genetic mutations that cause inherited eye diseases. By sequencing the DNA of 143 Pakistani families containing several members with retinitis pigmentosa, the project discovered that multiple affected individuals in five families had a never-before-seen change in a gene called CLCC1, which provides the genetic blueprint for building a channel that moves around chloride ions within cells. Around the same time, a research group in the UK found the same mutation in three other families with Pakistani ancestry and a family history of retinitis pigmentosa, which spurred a collaborative effort to investigate it.

“Finding that this mutation in an intracellular chloride channel caused the disorder threw us for a bit of a loop,” Dr. Hejtmancik says. “It’s not part of the other groups of proteins known to be involved in the disease. Finding something that’s completely outside those groups was a bit of a surprise for us.”

Prior to that discovery, the CLCC1 chloride channel had been largely ignored by the scientific community, with just a single study having examined it nearly three decades ago.2 Yet the gene’s sequence is remarkably similar across a number of different species from zebrafish to mice to humans, suggesting that it plays an important role in cells.

When Dr. Hejtmancik’s team inserted a mutated version of the CLCC1 channel into human and chicken retinal cells, the abnormal molecule accumulated in a structure called the endoplasmic reticulum that generates and transports cellular proteins. In addition, when Dr. Hejtmancik’s team knocked down the activity of the gene in lab-grown human retinal cells, roughly 10 percent of the cells activated a cellular self-destruct process and died, compared to less than one percent of control cells.

“It’s sort of a double whammy,” Dr. Hejtmancik says. “The absence of CLCC1’s function will kill the cell, and having that damaged protein hanging around in the endoplasmic reticulum probably doesn’t help either.”

Further experiments showed that zebrafish larvae without the CLCC1 gene had abnormal retinas with fewer photoreceptors, which showed signs of degeneration. Injecting these zebrafish with genetic material that allowed their cells to manufacture the CLCC1 channel partially reversed those abnormalities. Mice missing just one copy of the gene had similar retinal defects.

More work will be needed to pin down precisely what the CLCC1 chloride channel does in cells both within and outside the retina, as well as why the CLCC1 mutation causes retinitis pigmentosa. Even without that knowledge, Dr. Hejtmancik’s findings will enable genetic counseling for retinitis pigmentosa patients with the CLCC1 mutation, and further down the line it may be possible to correct the mutation’s consequences using gene therapy.

“We might clinically do some good for some patients at some point, especially if we can do gene therapy,” Dr. Hejtmancik says. “But in the near term, this study really serves as a guidepost for future investigations into the physiology and biochemistry of the retina. It provides a foundation for all the other studies that will be done, many of which will have practical implications.”

Subscribe to our weekly newsletter to stay up-to-date on the latest breakthroughs in the NIH Intramural Research Program.

References:

[1] Mutation in the intracellular chloride channel CLCC1 associated with autosomal recessive retinitis pigmentosa. Li L, Jiao X, D'Atri I, Ono F, Nelson R, Chan CC, Nakaya N, Ma Z, Ma Y, Cai X, Zhang L, Lin S, Hameed A, Chioza BA, Hardy H, Arno G, Hull S, Khan MI, Fasham J, Harlalka GV, Michaelides M, Moore AT, Coban Akdemir ZH, Jhangiani S, Lupski JR, Cremers FPM, Qamar R, Salman A, Chilton J, Self J, Ayyagari R, Kabir F, Naeem MA, Ali M, Akram J, Sieving PA, Riazuddin S, Baple EL, Riazuddin SA, Crosby AH, Hejtmancik JF. PLoS Genet. 2018 Aug 29;14(8):e1007504. doi: 10.1371/journal.pgen.1007504. [Epub ahead of print]

[2] Identification of a novel chloride channel expressed in the endoplasmic reticulum, golgi apparatus, and nucleus. Nagasawa M, Kanzaki M, Iino Y, Morishita Y, Kojima I. J Biol Chem. 2001 Jun 8;276(23):20413-8. Epub 2001 Mar 5.


Category: IRP Discoveries
Tags: genome, DNA, mutations, retinitis pigmentosa, eyes, sequencing, zebrafish, Test Tube Tuesday

Related Blog Posts

  • Dog Genome Yields Clues to Human Cancer
  • Mosquitos With Human Gene Hinder Malaria Transmission
  • IRP’s Charles Rotimi Elected to American Academy of Arts and Sciences
  • Reducing Stress Boosts Efficiency of Bacterial Factories
  • Gene Editing Reveals Potential Cancer Treatment Target

This page was last updated on Tuesday, January 30, 2024

Blog menu

  • Contributing Authors
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Melissa Glim
  • Categories
    • IRP Discoveries
    • Profiles
    • Events
    • NIH History
    • IRP Life

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search